Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study.

Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol. 2001 Sep; 22(5):619-24.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.